AR and prostate carcinoma: In this study, the effect of FUS-induced cavitation in combination with HT in the treatment of prostate cancer was further investigated using another prostate cancer cell line LNCap, and the therapeutic mechanism was evaluated from the perspectives of cell membrane disruption, DSBs, cell cycle arrest, and inhibiting the AR signal pathway of prostate cancer cells.